Blackstone Inc.
05/27/2026 | Press release | Distributed by Public on 05/27/2026 04:37
Apogee Therapeutics Announces $1.3 Billion Strategic Financing Collaboration with Blackstone Life Sciences to Advance Phase 3 Development and Commercialization of Zumilokibart
Our dedicated team works directly with private wealth managers, family offices and financial advisors to help their clients access alternative solutions.
Individual Investors
Please contact your financial advisor to learn more.
Financial Professional Inquiries
[email protected] +1 (212) 583-5200
Visit our dedicated site for financial advisors:
Blackstone Inc. published this content on May 27, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 27, 2026 at 10:37 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]